Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03260387 · ClinicalTrials.gov registry record
A Prospective Observational Study of TPIAT
A clinical trial of Pancreatitis and Pancreatitis, Chronic, sponsored by University of Minnesota.
- Active
- Registry status
- 433
- Enrollment target
- 12
- Study locations
NCT03260387: Active study of Pancreatitis and Pancreatitis, Chronic, sponsored by University of Minnesota.
NCT03260387 is a study of Pancreatitis and Pancreatitis, Chronic that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 433 participants, below the 597-participant average among 17 other Pancreatitis trials with a reported enrollment target (27% lower). The trial reports 12 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03260387, a study of Pancreatitis and Pancreatitis, Chronic, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- 433 participants
- Enrollment target
- 12
- Study locations
Study Summary
Multi-center, prospective, observational cohort study of patients undergoing total pancreatectomy with islet autotransplantation (TPIAT)
Primary Outcome
Visual Analog Pain Scale
Conditions Studied
Interventions
- PROCEDURE TPIAT
Study Locations (12)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Cleveland Clinic - Cleveland
- The Ohio State University Wexner Medical Center - Columbus
California
- University of California, San Francisco - San Francisco
Illinois
- The University of Chicago Medical Center - Chicago
Kentucky
- University of Louisville - Louisville
Maryland
- Johns Hopkins Hospital - Baltimore
Minnesota
- University of Minnesota - Minneapolis
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Pennsylvania
- University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 433 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2026-05-01 |
What the registry record for NCT03260387 still lists
NCT03260387 is an observational study that tracks outcomes without assigning an intervention. The registered 433 participants enrollment target is mid-sized for trials with a published cap, below the 597-participant average among 17 other Pancreatitis trials with a reported enrollment target (27% lower).
The record links to 3 conditions, with Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which TPIAT is the first listed.
NCT03260387 lists 12 locations in 10 states (Ohio, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT03260387 about?
NCT03260387 is a clinical study titled "A Prospective Observational Study of TPIAT". Multi-center, prospective, observational cohort study of patients undergoing total pancreatectomy with islet autotransplantation (TPIAT)
What is the current status of trial NCT03260387?
This trial is currently active not recruiting. The enrollment target is 433 participants. The study started on 2017-01-01. Estimated completion is 2026-05-01.
What conditions does trial NCT03260387 study?
This clinical trial studies the following conditions: Pancreatitis, Pancreatitis, Chronic, Pancreatectomy; Hyperglycemia.
What interventions are being tested in trial NCT03260387?
The interventions under investigation include: TPIAT (PROCEDURE).
Who is sponsoring clinical trial NCT03260387?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03260387 being conducted?
This trial has 12 study locations across California, Illinois, Kentucky, Maryland, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03260387's enrollment target sits among peer trials
433 6th of 17 higher than 12 of 17 other Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
RECRUITING
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Scrambler Therapy in Chronic Pancreatitis
RECRUITING · NA
-
PROMs After Pancreatectomy
RECRUITING
-
Pancreas Registry and High Risk Registry
RECRUITING
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI